TUMOR REGISTRY PROFILE

2000 CANCER INCIDENCE BY SITE AND SEX
Analytical Case for 2001 (as percent of total)

† Number of cases were insignificant

*Includes Carcinoma in-situ of cervix

 

 

 

 
Total
Perc
Sex
Class of Case
Status
AJCC Stage/Analytic Only
Primary Site
N*
%
M
F
Analy
N-Analy
Alive
Exp
00
01
02
03
04
UNK
N/A
All Sites
298
100
128
170
281
17
230
68
46
59
68
40
36
15
17
Breast
66
22.1
0
66
66
0
66
0
9
21
27
6
1
1
1
Digestive Organs
59
19.9
34
25
56
3
44
15
2
12
11
11
10
7
3
Colon
30
10.1
13
17
30
0
25
5
1
8
8
6
2
5
0
Rectosigmoid Junction
6
2.0
5
1
6
0
4
2
1
2
1
0
1
0
1
Esophagus
5
1.7
5
0
4
1
3
2
0
0
0
2
1
1
0
Stomach
5
1.7
3
2
5
0
3
2
0
1
0
2
2
0
0
Liver & Biliary Passages
4
1.3
3
1
2
2
2
2
0
0
0
0
1
1
0
Pancreas
2
0.7
2
0
2
0
0
2
0
0
0
0
2
0
0
Anus/Anal Canal
2
0.7
0
2
2
0
2
0
0
1
1
0
0
0
0
Rectum
2
0.7
2
0
2
0
2
0
0
0
1
0
0
0
1
Small Intestine
2
0.7
1
1
2
0
2
0
0
0
0
0
1
0
1
Gallbladder
1
0.3
0
1
1
0
1
0
0
0
0
1
0
0
0
Bronchus & Lung
44
14.8
27
17
38
6
13
31
0
4
3
8
18
4
1
Female Genital Organs
34
11.4
0
34
34
0
33
1
26
4
0
2
2
0
0
Cervix*
24
8.1
0
24
24
0
24
0
24
0
0
0
0
0
0
Uterus
6
2.0
0
6
6
0
5
1
0
4
0
1
1
0
0
Vulva
2
0.7
0
2
2
0
2
0
2
0
0
0
0
0
0
Ovary
2
0.7
0
2
2
0
2
0
0
0
0
1
1
0
0
Male Genital Organs
31
10.4
31
0
26
5
26
5
0
2
17
4
1
2
0
Prostate Gland
27
9.1
27
0
22
5
22
5
0
0
16
4
1
1
0
Testis
4
1.3
4
0
4
0
4
0
0
2
1
0
0
1
0
Urinary Organs
25
8.4
19
6
24
1
21
4
9
8
3
1
2
1
0
Bladder
18
6.0
14
4
17
1
17
1
9
6
2
0
0
0
0
Kidney
5
1.7
3
2
5
0
4
1
0
1
1
1
1
1
0
Renal Pelvis
2
0.7
2
0
2
0
0
2
0
1
0
0
1
0
0
Lymphomas
15
5.0
4
11
15
0
10
5
0
2
5
5
0
0
3
Non-Hodgkin's
12
4.0
3
9
12
0
9
3
0
2
4
3
0
0
3
Hodgkin's
3
1.0
1
2
3
0
1
2
0
0
1
2
0
0
0
Head/Neck
8
2.6
6
2
8
0
8
0
0
3
0
2
2
0
1
Tongue
3
1.0
3
0
3
0
3
0
0
0
0
1
2
0
0
Larynx
3
1.0
2
1
3
0
3
0
0
3
0
0
0
0
0
Nasopharynx
1
0.3
1
0
1
0
1
0
0
0
0
1
0
0
0
Other
1
0.3
0
1
1
0
1
0
0
0
0
0
0
0
1
Unknown Primary
5
1.7
3
2
4
1
2
3
0
0
0
0
0
0
4
Leukemias
3
1.0
1
2
3
0
2
1
0
0
0
0
0
0
3
Thyroid Gland
3
1.0
0
3
3
0
3
0
0
2
1
0
0
0
0
Multiple Myeloma
2
0.7
2
0
2
0
0
2
0
0
0
1
0
0
1
Soft Tissue
1
0.3
0
1
1
0
1
0
0
0
1
0
0
0
0
Skin**
1
0.3
1
0
1
0
1
0
0
1
0
0
0
0
0
Eye & Orbit
1
0.3
0
1
0
1
0
1
0
0
0
0
0
0
0

* Includes in-situ cases
** Excludes basal and squamous cell carcinoma of the skin

Evaluate Your Screening Procedure. It should:

1) Be simple and safe to administer,

2) Be sensitive enough to pick up a cancer at an early stage,

3) Have few false positive and false negative results,

4) Detect a cancer that is frequent enough in the population to make it worthwhile doing large scale testing,

4) Be cost effective and, importantly,

5) Detect a cancer for which effective therapy is available.

 

Home | The Year in Review | Tumor Registry Report | Breast Care Program
Related Services | 2001 Cancer Cases | Questions & Answers